Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab.
about
Biomarkers of Diabetic Retinopathy.Effect of bevacizumab on the expression of fibrosis-related inflammatory mediators in ARPE-19 cells.Kaempferol inhibited VEGF and PGF expression and in vitro angiogenesis of HRECs under diabetic-like environment.Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes.The G-Protein-Coupled Chemoattractant Receptor Fpr2 Exacerbates High Glucose-Mediated Proinflammatory Responses of Müller Glial Cells.
P2860
Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Changes in vitreous VEGF, bFGF ...... fter intravitreal bevacizumab.
@en
type
label
Changes in vitreous VEGF, bFGF ...... fter intravitreal bevacizumab.
@en
prefLabel
Changes in vitreous VEGF, bFGF ...... fter intravitreal bevacizumab.
@en
P2093
P2860
P1476
Changes in vitreous VEGF, bFGF ...... fter intravitreal bevacizumab.
@en
P2093
Hu-Shan Cui
Xiao-Hong Jin
Yuan-Min Dai
P2860
P304
P356
10.3980/J.ISSN.2222-3959.2015.06.22
P577
2015-12-18T00:00:00Z